Person · CIK 1522780

Edward M. MD Kaye

CEO at Stoke Therapeutics; director at Cytokinetics and Avidity Biosciences

Earlier: Sarepta Therapeutics

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$18.7M

Noticed on Form 144$46M

Bought on Form 4$9K

Companies4

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

Company	Security	Held	Shares or units	As of
Cytokinetics CYTK	Common Stock	Directly	10,629	Oct 16, 2026 · Filing · EDGAR
Cytokinetics CYTK	Non-Qualified Stock Option (Right to Buy) exercise $77.15, expires May 26, 2036, into Common Stock	Directly	4,301	May 27, 2026 · Filing · EDGAR
Stoke Therapeutics STOK	Common Stock	Directly	124,557	Aug 18, 2026 · Filing · EDGAR
Sarepta Therapeutics	Common Stock	Directly	71,229	Aug 3, 2017 · Filing · EDGAR

Sold and noticed by quarter

Sold (Form 4) Noticed (Form 144) Bought (Form 4)

Quarterly totals as a table

Quarter	Sold (Form 4)	Noticed (Form 144)	Bought (Form 4)
Q4 2026	—	$38.4M	—
Q3 2026	$403K	—	—
Q2 2026	$223K	$225K	—
Q4 2025	$5.4M	$4.8M	—
Q3 2025	$2.2M	$1.8M	—
Q2 2025	$117K	$118K	—
Q1 2025	$164K	—	—
Q4 2024	$167K	—	—
Q2 2024	$654K	$589K	—
Q1 2024	$68K	—	—
Q3 2022	$571K	Not machine-readable	—
Q4 2021	$675K	Not machine-readable	—
Q4 2020	$3.4M	Not machine-readable	—
Q3 2017	$410K	Not machine-readable	—
Q3 2016	$4.4M	Not machine-readable	—
Q1 2015	—	—	$9K

Form 144 notices went onto EDGAR as structured data on April 13, 2023. Earlier notices were filed on paper and cannot be read here, so those quarters show no noticed amount.

Planned sales (Form 144) and the sales that followed

Each Form 144 notice of a planned sale, grouped by broker and 10b5-1 plan, with the Form 4 sales we matched to it.

How we match

A Form 144 is a notice of a planned sale by an affiliate. SEC Tracker matches each notice to Form 4 sales by the same person at the same company within 90 days of the notice, up to the shares noticed. The match is our inference, not something either filing states.

Notice date	Noticed	Planned sale	Outcome	Links
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · No 10b5-1 plan stated · 1 notice
Oct 21, 2026	1,496,042 · ~$38.4M	Oct 21, 2026	Not sold yet	Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 2, 2026 · 1 notice
Jun 1, 2026	2,933 · ~$225K	Jun 1, 2026	Sold as noticed Sold 2,933 at $76.09 on Jun 1 · $223K Form 4	Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 30, 2024 · 5 notices
Dec 8, 2025	13,430 · ~$415K	Dec 8, 2025	Sold as noticed Sold 13,320 in 4 sales, Dec 4 to Dec 5 · $415K Form 4	Filing · EDGAR
Dec 5, 2025	2,181 · ~$68K	Dec 5, 2025	Partly sold Sold 1,731 in 3 sales, Dec 2 to Dec 3 · $52K likely match Form 4	Filing · EDGAR
Oct 8, 2025	25,000 · ~$683K	Oct 8, 2025	Sold as noticed Sold 25,000 at $30.00 on Oct 8 · $750K Form 4	Filing · EDGAR
Oct 3, 2025	42,461 · ~$1.1M	Oct 3, 2025	Sold as noticed Sold 42,866 in 2 sales, Oct 3 to Dec 2 · $1.1M Form 4 (1) · Form 4 (2)	Filing · EDGAR
Aug 29, 2025	61,885 · ~$1.2M	Aug 29, 2025	Sold as noticed Sold 61,885 in 3 sales, Aug 29 to Sep 3 · $1.2M Form 4	Filing · EDGAR
Cytokinetics CYTK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Mar 6, 2025 · 6 notices
Dec 1, 2025	28,064 · ~$1.9M	Dec 1, 2025	Sold as noticed Sold 28,064 at $66.72 on Dec 1 · $1.9M Form 4	Filing · EDGAR
Nov 11, 2025	5,175 · ~$322K	Nov 11, 2025	Sold as noticed Sold 5,175 at $65.08 on Nov 11 · $337K Form 4	Filing · EDGAR
Oct 6, 2025	6,757 · ~$385K	Oct 6, 2025	Sold as noticed Sold 6,757 at $60.00 on Oct 6 · $405K Form 4	Filing · EDGAR
Sep 30, 2025	6,695 · ~$361K	Sep 30, 2025	Sold as noticed Sold 6,695 at $55.08 on Sep 30 · $369K Form 4	Filing · EDGAR
Sep 2, 2025	6,756 · ~$239K	Sep 2, 2025	Sold as noticed Sold 6,756 at $50.00 on Sep 2 · $338K Form 4	Filing · EDGAR
Jun 5, 2025	3,636 · ~$118K	Jun 5, 2025	Sold as noticed Sold 3,636 at $32.10 on Jun 5 · $117K Form 4	Filing · EDGAR
Stoke Therapeutics STOK · Morgan Stanley Smith Barney · 10b5-1 plan adopted Dec 26, 2023 · 1 notice
May 20, 2024	42,350 · ~$589K	May 20, 2024	Sold as noticed Sold 42,350 in 2 sales, May 20 to May 20 · $654K Form 4	Filing · EDGAR
Sales without a matching Form 144 · 25 sales No matching Form 144 found. Not every sale needs one: small sales and sales by people who are not affiliates are exempt.
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 637 at $32.47 on Aug 18, 2026 · $21K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 11,930 at $32.01 on Aug 18, 2026 · $382K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,331 at $33.10 on Dec 8, 2025 · $44K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 8,274 at $32.52 on Dec 8, 2025 · $269K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 3,825 at $31.44 on Dec 8, 2025 · $120K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 1,681 at $31.15 on Dec 5, 2025 · $52K (10b5-1 plan)	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 12,126 at $18.24 on Aug 18, 2025 · $221K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 8,907 at $8.27 on Mar 19, 2025 · $74K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 10,382 at $8.67 on Mar 18, 2025 · $90K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 6,786 at $12.99 on Dec 9, 2024 · $88K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 6,170 at $12.78 on Dec 6, 2024 · $79K	Filing · EDGAR
—	—	—	Sold without notice Stoke Therapeutics (STOK): Sold 11,150 at $6.10 on Mar 19, 2024 · $68K	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 11,428 at $50.00 on Aug 5, 2022 · $571K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 15,000 at $45.00 on Dec 23, 2021 · $675K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 5,194 at $60.00 on Dec 18, 2020 · $312K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 19,806 at $60.00 on Dec 17, 2020 · $1.2M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 12,152 at $50.00 on Nov 27, 2020 · $608K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Stoke Therapeutics (STOK): Sold 12,848 at $50.00 on Nov 25, 2020 · $642K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Cytokinetics (CYTK): Sold 20,000 at $30.00 on Oct 5, 2020 · $600K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Sarepta Therapeutics: Sold 10,000 at $41.00 on Jul 20, 2017 · $410K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Sarepta Therapeutics: Sold 40,179 at $60.00 on Sep 22, 2016 · $2.4M (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Sarepta Therapeutics: Sold 10,405 at $50.00 on Sep 19, 2016 · $520K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Sarepta Therapeutics: Sold 947 at $50.00 on Sep 19, 2016 · $47K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Sarepta Therapeutics: Sold 13,000 at $50.00 on Sep 19, 2016 · $650K (10b5-1 plan)	Filing · EDGAR
—	—	—	Notice not machine-readable Sarepta Therapeutics: Sold 24,557 at $30.00 on Sep 14, 2016 · $737K (10b5-1 plan)	Filing · EDGAR

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Stoke Therapeutics STOK CEO · filings 2019 to 2026 · sold $8.5M · $42.4M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 18, 2026	Open-market or private sale	−11,930	$32.01	$382K	125,194 direct	Filing · EDGAR
Aug 18, 2026	Open-market or private sale	−637	$32.47	$21K	124,557 direct	Filing · EDGAR
Aug 14, 2026	Option or RSU exercised or converted	+26,250			137,124 direct	Filing · EDGAR
Aug 14, 2026	Option or RSU exercised or converted Performance Stock Units	−26,250			0 direct	Filing · EDGAR
Jun 3, 2026	Grant or award from the company Director Stock Option (Right to Buy)	+17,786			17,786 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted	+35,500			84,624 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted	+26,250			110,874 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted Restricted Stock Units	−35,500			35,500 direct	Filing · EDGAR
Mar 15, 2026	Option or RSU exercised or converted Restricted Stock Units	−26,250			52,500 direct	Filing · EDGAR
Dec 8, 2025	Sale under a 10b5-1 plan	−3,825	$31.44	$120K	58,729 direct	Filing · EDGAR
Dec 8, 2025	Sale under a 10b5-1 plan	−8,274	$32.52	$269K	50,455 direct	Filing · EDGAR
Dec 8, 2025	Sale under a 10b5-1 plan	−1,331	$33.10	$44K	49,124 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−6,367	$31.33	$199K	64,735 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−1,681	$31.15	$52K	63,054 direct	Filing · EDGAR
Dec 5, 2025	Sale under a 10b5-1 plan	−500	$31.85	$16K	62,554 direct	Filing · EDGAR
Dec 4, 2025	Sale under a 10b5-1 plan	−5,222	$30.76	$161K	72,333 direct	Filing · EDGAR
Dec 4, 2025	Sale under a 10b5-1 plan	−1,231	$31.32	$39K	71,102 direct	Filing · EDGAR
Dec 3, 2025	Option or RSU exercised or converted	+26,250			77,555 direct	Filing · EDGAR
Dec 3, 2025	Option or RSU exercised or converted Performance Stock Units	−26,250			0 direct	Filing · EDGAR
Dec 3, 2025	Open-market or private sale	−419	$30.34	$13K	51,956 direct	Filing · EDGAR
Dec 3, 2025	Open-market or private sale	−651	$30.85	$20K	51,305 direct	Filing · EDGAR
Dec 2, 2025	Open-market or private sale	−661	$29.56	$20K	52,780 direct	Filing · EDGAR
Dec 2, 2025	Open-market or private sale	−405	$30.14	$12K	52,375 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted Restricted Stock Units	−4,317			0 direct	Filing · EDGAR
Oct 8, 2025	Option or RSU exercised or converted	+25,000	$0.60	$15K	74,124 direct	Filing · EDGAR
Oct 8, 2025	Sale under a 10b5-1 plan	−25,000	$30.00	$750K	49,124 direct	Filing · EDGAR
Oct 8, 2025	Option or RSU exercised or converted Stock Option (Right to Buy)	−25,000			542,801 direct	Filing · EDGAR
Oct 3, 2025	Sale under a 10b5-1 plan	−42,461	$25.09	$1.1M	49,124 direct	Filing · EDGAR
Sep 4, 2025	Returned to the company Employee Stock Option (Right to Buy)	−178,500			37,500 direct	Filing · EDGAR
Sep 4, 2025	Returned to the company Restricted Stock Units	−144,000			0 direct	Filing · EDGAR
Sep 3, 2025	Sale under a 10b5-1 plan	−45,996	$20.13	$926K	91,585 direct	Filing · EDGAR
Sep 2, 2025	Sale under a 10b5-1 plan	−14,860	$20.14	$299K	137,581 direct	Filing · EDGAR
Aug 29, 2025	Sale under a 10b5-1 plan	−1,029	$20.00	$21K	152,441 direct	Filing · EDGAR
Aug 18, 2025	Open-market or private sale	−12,126	$18.24	$221K	153,470 direct	Filing · EDGAR
Aug 14, 2025	Option or RSU exercised or converted	+26,250			165,596 direct	Filing · EDGAR
Aug 14, 2025	Grant or award from the company Performance Stock Units	+52,500			52,500 direct	Filing · EDGAR
Aug 14, 2025	Option or RSU exercised or converted Performance Stock Units	−26,250			26,250 direct	Filing · EDGAR
Mar 20, 2025	Grant or award from the company Employee Stock Option (Right to Buy)	+216,000			216,000 direct	Filing · EDGAR
Mar 20, 2025	Grant or award from the company Restricted Stock Units	+144,000			144,000 direct	Filing · EDGAR
Mar 19, 2025	Open-market or private sale	−8,907	$8.27	$74K	139,346 direct	Filing · EDGAR
Mar 18, 2025	Open-market or private sale	−10,382	$8.67	$90K	148,253 direct	Filing · EDGAR
Mar 15, 2025	Option or RSU exercised or converted	+35,500			132,385 direct	Filing · EDGAR
Mar 15, 2025	Option or RSU exercised or converted	+26,250			158,635 direct	Filing · EDGAR
Mar 15, 2025	Option or RSU exercised or converted Restricted Stock Units	−35,500			71,000 direct	Filing · EDGAR
Mar 15, 2025	Option or RSU exercised or converted Restricted Stock Units	−26,250			78,750 direct	Filing · EDGAR
Dec 30, 2024	Option or RSU exercised or converted	+35,000	$0.60	$21K	96,885 direct	Filing · EDGAR
Dec 30, 2024	Option or RSU exercised or converted Employee Stock Option (Right to Buy)	−35,000			567,801 direct	Filing · EDGAR
Dec 9, 2024	Open-market or private sale	−6,786	$12.99	$88K	61,885 direct	Filing · EDGAR
Dec 6, 2024	Open-market or private sale	−6,170	$12.78	$79K	68,671 direct	Filing · EDGAR
Dec 3, 2024	Option or RSU exercised or converted	+26,250			74,841 direct	Filing · EDGAR
Dec 3, 2024	Grant or award from the company Performance Stock Units	+52,500			52,500 direct	Filing · EDGAR
Dec 3, 2024	Option or RSU exercised or converted Performance Stock Units	−26,250			26,250 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted	+4,317			53,441 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted	+21,591			48,591 direct	Filing · EDGAR
Dec 1, 2024	Option or RSU exercised or converted Restricted Stock Unit (RSU)	−21,591			4,317 direct	Filing · EDGAR
May 20, 2024	Sale under a 10b5-1 plan	−39,686	$15.39	$611K	29,664 direct	Filing · EDGAR
May 20, 2024	Sale under a 10b5-1 plan	−2,664	$16.05	$43K	27,000 direct	Filing · EDGAR
Mar 27, 2024	Grant or award from the company Employee Stock Option (Right to Buy)	+159,000			159,000 direct	Filing · EDGAR
Mar 27, 2024	Grant or award from the company Restricted Stock Units	+105,000			105,000 direct	Filing · EDGAR
Mar 19, 2024	Open-market or private sale	−11,150	$6.10	$68K	69,350 direct	Filing · EDGAR

22 earlier transactions are in the filing list below.

Cytokinetics CYTK Director · filings 2016 to 2026 · sold $5.5M · $3.6M noticed on Form 144

Date	Transaction	Shares	Price	Value	Held after	Source
Oct 16, 2026	Grant or award from the company	+195	$63.92	$12K	10,629 direct	Filing · EDGAR
Jul 15, 2026	Grant or award from the company	+151	$82.62	$12K	10,434 direct	Filing · EDGAR
Jun 1, 2026	Sale under a 10b5-1 plan	−2,933	$76.09	$223K	10,283 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company	+2,851			13,216 direct	Filing · EDGAR
May 27, 2026	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+4,301			4,301 direct	Filing · EDGAR
Apr 15, 2026	Grant or award from the company	+191	$65.37	$12K	10,365 direct	Filing · EDGAR
Jan 15, 2026	Grant or award from the company	+197	$63.44	$12K	10,174 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted	+8,064	$12.40	$100K	18,041 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted	+20,000	$14.25	$285K	38,041 direct	Filing · EDGAR
Dec 1, 2025	Sale under a 10b5-1 plan	−28,064	$66.72	$1.9M	9,977 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−8,064			0 direct	Filing · EDGAR
Dec 1, 2025	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−20,000			0 direct	Filing · EDGAR
Nov 11, 2025	Option or RSU exercised or converted	+5,175	$9.66	$50K	15,152 direct	Filing · EDGAR
Nov 11, 2025	Sale under a 10b5-1 plan	−5,175	$65.08	$337K	9,977 direct	Filing · EDGAR
Nov 11, 2025	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−5,175			0 direct	Filing · EDGAR
Oct 15, 2025	Grant or award from the company	+199	$62.80	$12K	9,977 direct	Filing · EDGAR
Oct 6, 2025	Sale under a 10b5-1 plan	−6,757	$60.00	$405K	9,778 direct	Filing · EDGAR
Sep 30, 2025	Sale under a 10b5-1 plan	−6,695	$55.08	$369K	16,535 direct	Filing · EDGAR
Sep 2, 2025	Sale under a 10b5-1 plan	−6,756	$50.00	$338K	23,230 direct	Filing · EDGAR
Jul 15, 2025	Grant or award from the company	+328	$38.01	$12K	29,986 direct	Filing · EDGAR
Jun 5, 2025	Sale under a 10b5-1 plan	−3,636	$32.10	$117K	29,658 direct	Filing · EDGAR
May 14, 2025	Grant or award from the company	+7,333			33,294 direct	Filing · EDGAR
May 14, 2025	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+10,880			10,880 direct	Filing · EDGAR
Apr 15, 2025	Grant or award from the company	+324	$38.56	$12K	25,961 direct	Filing · EDGAR
Jan 2, 2025	Grant or award from the company	+255	$48.93	$12K	25,637 direct	Filing · EDGAR
Oct 1, 2024	Grant or award from the company	+237	$52.60	$12K	25,382 direct	Filing · EDGAR
Jul 1, 2024	Grant or award from the company	+228			25,145 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company	+5,600			24,917 direct	Filing · EDGAR
May 15, 2024	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+3,636			3,636 direct	Filing · EDGAR
Jan 2, 2024	Grant or award from the company	+148	$84.12	$12K	19,317 direct	Filing · EDGAR
Oct 2, 2023	Grant or award from the company	+448	$27.88	$12K	19,169 direct	Filing · EDGAR
Jul 3, 2023	Grant or award from the company	+374	$33.36	$12K	18,721 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company	+5,000			18,347 direct	Filing · EDGAR
May 10, 2023	Grant or award from the company Non-Qualified Stock Option (Right to Buy)	+10,000			10,000 direct	Filing · EDGAR
Apr 3, 2023	Grant or award from the company	+298	$37.71	$11K	13,347 direct	Filing · EDGAR
Jan 3, 2023	Grant or award from the company	+253	$44.35	$11K	13,049 direct	Filing · EDGAR
Oct 3, 2022	Grant or award from the company	+220	$51.11	$11K	12,796 direct	Filing · EDGAR
Aug 5, 2022	Option or RSU exercised or converted	+11,428	$8.75	$100K	24,004 direct	Filing · EDGAR
Aug 5, 2022	Sale under a 10b5-1 plan	−11,428	$50.00	$571K	12,576 direct	Filing · EDGAR
Aug 5, 2022	Option or RSU exercised or converted Non-Qualified Stock Option (Right to Buy)	−11,428			0 direct	Filing · EDGAR
Jul 1, 2022	Grant or award from the company	+274	$41.00	$11K	12,576 direct	Filing · EDGAR
May 10, 2022	Grant or award from the company	+5,000			12,302 direct	Filing · EDGAR
May 10, 2022	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR
Apr 1, 2022	Grant or award from the company	+293	$38.38	$11K	7,302 direct	Filing · EDGAR
Jan 3, 2022	Grant or award from the company	+244	$46.00	$11K	7,009 direct	Filing · EDGAR
Dec 23, 2021	Option or RSU exercised or converted	+15,000	$7.61	$114K	21,765 direct	Filing · EDGAR
Dec 23, 2021	Sale under a 10b5-1 plan	−15,000	$45.00	$675K	6,765 direct	Filing · EDGAR
Dec 23, 2021	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−15,000			0 direct	Filing · EDGAR
Oct 1, 2021	Grant or award from the company	+306	$36.74	$11K	6,765 direct	Filing · EDGAR
Jul 7, 2021	Grant or award from the company	+63	$19.77	$1K	6,459 direct	Filing · EDGAR
Jul 1, 2021	Grant or award from the company	+476	$20.98	$10K	6,396 direct	Filing · EDGAR
May 12, 2021	Grant or award from the company	+5,000			5,920 direct	Filing · EDGAR
May 12, 2021	Grant or award from the company Non-Qualified Stock Option (right to buy)	+10,000			10,000 direct	Filing · EDGAR
Apr 1, 2021	Grant or award from the company	+409	$24.44	$10K	920 direct	Filing · EDGAR
Jan 4, 2021	Grant or award from the company	+511	$19.56	$10K	511 direct	Filing · EDGAR
Oct 5, 2020	Option or RSU exercised or converted	+20,000	$7.61	$152K	20,000 direct	Filing · EDGAR
Oct 5, 2020	Sale under a 10b5-1 plan	−20,000	$30.00	$600K	0 direct	Filing · EDGAR
Oct 5, 2020	Option or RSU exercised or converted Non-Qualified Stock Option (right to buy)	−20,000			15,000 direct	Filing · EDGAR
May 13, 2020	Grant or award from the company Non-Qualified Stock Option (right to buy)	+20,000	$21.61	$432K	20,000 direct	Filing · EDGAR
Feb 12, 2020	Grant or award from the company Non-Qualified Stock Option (right to buy)	+8,248	$15.43	$127K	8,248 direct	Filing · EDGAR

9 earlier transactions are in the filing list below.

Avidity Biosciences RNA Director · filings 2020 to 2026

Date	Transaction	Shares	Held after	Source
Feb 27, 2026	Returned to the company	−6,692	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−10,034	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−13,489	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−22,000	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−22,000	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−15,000	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−11,323	0 direct	Filing · EDGAR
Feb 27, 2026	Returned to the company Stock Option (Right to Buy)	−9,534	0 direct	Filing · EDGAR
Jun 10, 2025	Grant or award from the company	+6,692	6,692 direct	Filing · EDGAR
Jun 10, 2025	Grant or award from the company Stock Option (Right to Buy)	+10,034	10,034 direct	Filing · EDGAR
Jun 13, 2024	Grant or award from the company Stock Option (Right to Buy)	+13,489	13,489 direct	Filing · EDGAR
Jun 15, 2023	Grant or award from the company Stock Option (Right to Buy)	+22,000	22,000 direct	Filing · EDGAR
Jun 15, 2022	Grant or award from the company Stock Option (Right to Buy)	+22,000	22,000 direct	Filing · EDGAR
Jun 16, 2021	Grant or award from the company Stock Option (Right to Buy)	+15,000	15,000 direct	Filing · EDGAR

Sarepta Therapeutics President & CEO · filings 2011 to 2017 · sold $4.8M · bought $9K

Date	Transaction	Shares	Price	Value	Held after	Source
Aug 3, 2017	Option or RSU exercised or converted	+35,461			87,932 direct	Filing · EDGAR
Aug 3, 2017	Shares withheld for tax or exercise price	−16,703	$37.88	$633K	71,229 direct	Filing · EDGAR
Aug 3, 2017	Option or RSU exercised or converted Restricted Stock Units	−35,461			0 direct	Filing · EDGAR
Jul 20, 2017	Shares withheld for tax or exercise price	−4,349	$40.93	$178K	62,471 direct	Filing · EDGAR
Jul 20, 2017	Sale under a 10b5-1 plan	−10,000	$41.00	$410K	52,471 direct	Filing · EDGAR
Apr 20, 2017	Shares withheld for tax or exercise price	−4,349	$32.54	$142K	66,820 direct	Filing · EDGAR
Mar 10, 2017	Grant or award from the company Non-Qualified Stock Option (right to buy)	+95,623			95,623 direct	Filing · EDGAR
Mar 10, 2017	Grant or award from the company Incentive Stock Option (right to buy)	+4,377			4,377 direct	Filing · EDGAR
Jan 20, 2017	Shares withheld for tax or exercise price	−4,466	$32.66	$146K	71,169 direct	Filing · EDGAR
Nov 9, 2016	Option or RSU exercised or converted	+3,000	$8.28	$25K	75,635 direct	Filing · EDGAR
Nov 9, 2016	Option or RSU exercised or converted Incentive Stock Option (right to buy)	−3,000			45,309 direct	Filing · EDGAR
Oct 20, 2016	Shares withheld for tax or exercise price	−4,348	$49.05	$213K	72,635 direct	Filing · EDGAR
Sep 22, 2016	Option or RSU exercised or converted	+40,179	$8.28	$333K	117,162 direct	Filing · EDGAR
Sep 22, 2016	Sale under a 10b5-1 plan	−40,179	$60.00	$2.4M	76,983 direct	Filing · EDGAR
Sep 22, 2016	Option or RSU exercised or converted Non-Qualified Stock Options (right to buy)	−40,179	$8.28	$333K	40,179 direct	Filing · EDGAR
Sep 19, 2016	Option or RSU exercised or converted	+13,000	$8.28	$108K	89,983 direct	Filing · EDGAR
Sep 19, 2016	Sale under a 10b5-1 plan	−13,000	$50.00	$650K	76,983 direct	Filing · EDGAR
Sep 19, 2016	Option or RSU exercised or converted	+947	$5.40	$5K	77,930 direct	Filing · EDGAR
Sep 19, 2016	Sale under a 10b5-1 plan	−947	$50.00	$47K	76,983 direct	Filing · EDGAR
Sep 19, 2016	Option or RSU exercised or converted	+10,405	$5.40	$56K	87,388 direct	Filing · EDGAR
Sep 19, 2016	Sale under a 10b5-1 plan	−10,405	$50.00	$520K	76,983 direct	Filing · EDGAR
Sep 19, 2016	Option or RSU exercised or converted Non-Qualified Stock Options (right to buy)	−13,000	$8.28	$108K	80,358 direct	Filing · EDGAR
Sep 19, 2016	Option or RSU exercised or converted Incentive Stock Options (right to buy)	−947	$5.40	$5K	0 direct	Filing · EDGAR
Sep 19, 2016	Option or RSU exercised or converted Non-Qualified Stock Options (right to buy)	−10,405	$5.40	$56K	0 direct	Filing · EDGAR
Sep 14, 2016	Sale under a 10b5-1 plan	−24,557	$30.00	$737K	76,983 direct	Filing · EDGAR
Aug 31, 2016	Shares withheld for tax or exercise price	−1,487	$26.07	$39K	101,540 direct	Filing · EDGAR
Jul 20, 2016	Shares withheld for tax or exercise price	−3,001	$22.46	$67K	103,027 direct	Filing · EDGAR
Apr 20, 2016	Shares withheld for tax or exercise price	−3,001	$19.71	$59K	106,028 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company	−4,704			109,029 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company Incentive Stock Option (right to buy)	+4,574			4,574 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company Non- Qualified Stock Option (right to buy)	+95,426			95,426 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company Incentive Stock Option (right to buy)	+1,389			1,389 direct	Filing · EDGAR
Feb 29, 2016	Grant or award from the company Non- Qualified Stock Option (right to buy)	+98,611			98,611 direct	Filing · EDGAR
Jan 20, 2016	Shares withheld for tax or exercise price	−3,368	$13.26	$45K	103,525 direct	Filing · EDGAR
Oct 20, 2015	Shares withheld for tax or exercise price	−3,001	$26.74	$80K	106,893 direct	Filing · EDGAR
Jul 20, 2015	Shares withheld for tax or exercise price	−3,000	$33.48	$100K	109,094 direct	Filing · EDGAR
Apr 20, 2015	Grant or award from the company	+110,783			112,094 direct	Filing · EDGAR
Feb 27, 2015	Open-market or private purchase	+800	$11.82	$9K	1,311 direct	Filing · EDGAR
Feb 27, 2015	Grant or award from the company Incentive Stock Option (right to buy)	+9,200			9,200 direct	Filing · EDGAR
Feb 27, 2015	Grant or award from the company Non-Qualified Stock Option (right to buy)	+153,800			153,800 direct	Filing · EDGAR
Feb 28, 2014	Grant or award from the company Incentive Stock Option (right to buy)	+2,292			2,292 direct	Filing · EDGAR
Feb 28, 2014	Grant or award from the company Non-Qualified Stock Option (right to buy)	+52,708			52,708 direct	Filing · EDGAR
Jun 4, 2013	Grant or award from the company Incentive Stock Option (right to buy)	+2,863			2,863 direct	Filing · EDGAR
Jun 4, 2013	Grant or award from the company Non-Qualified Stock Option (right to buy)	+42,137			42,137 direct	Filing · EDGAR
Jun 4, 2013	Grant or award from the company Non-Qualified Stock Option (right to buy)	+45,000			45,000 direct	Filing · EDGAR
Aug 23, 2012	Grant or award from the company Stock Option (Right to Buy)	+79,000			79,000 direct	Filing · EDGAR
Apr 24, 2012	Grant or award from the company Stock Option (right to buy)	+68,110			68,110 direct	Filing · EDGAR
Jun 20, 2011	Grant or award from the company Stock Option (right to buy)	+850,000			850,000 direct	Filing · EDGAR

All 137 Forms 3, 4, 5 and 144

Filed	Form	Company	Links
Oct 21, 2026	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Oct 20, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 18, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 16, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 5, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jun 1, 2026	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jun 1, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 27, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 15, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 17, 2026	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Feb 27, 2026	Form 4	Avidity Biosciences RNA	Filing · EDGAR
Jan 16, 2026	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 10, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 8, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 3, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 2, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 1, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Nov 12, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Nov 12, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 10, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Oct 8, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Oct 7, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Oct 6, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Oct 6, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 3, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Sep 30, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Sep 30, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Sep 5, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Sep 3, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Sep 2, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Sep 2, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 29, 2025	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
Aug 20, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Aug 18, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 12, 2025	Form 4	Avidity Biosciences RNA	Filing · EDGAR
Jun 5, 2025	Form 144	Cytokinetics CYTK	Filing · EDGAR
Jun 5, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 14, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 16, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 20, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 18, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jan 6, 2025	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 2, 2025	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 11, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 10, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 10, 2024	Form 4/A	Stoke Therapeutics STOK	Filing · EDGAR
Dec 5, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 3, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Oct 3, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 3, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 14, 2024	Form 4	Avidity Biosciences RNA	Filing · EDGAR
Jun 7, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 22, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 20, 2024	Form 144	Stoke Therapeutics STOK	Filing · EDGAR
May 16, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 19, 2024	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jan 3, 2024	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 5, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Oct 3, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Sep 8, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jul 5, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 20, 2023	Form 4	Avidity Biosciences RNA	Filing · EDGAR
May 18, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 5, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 17, 2023	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jan 4, 2023	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 9, 2022	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Oct 5, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 8, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 12, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 17, 2022	Form 4	Avidity Biosciences RNA	Filing · EDGAR
May 26, 2022	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
May 11, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 1, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 17, 2022	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jan 4, 2022	Form 4	Cytokinetics CYTK	Filing · EDGAR
Dec 23, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Oct 4, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 8, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jul 2, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 16, 2021	Form 4	Avidity Biosciences RNA	Filing · EDGAR
May 13, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 5, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Mar 4, 2021	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Jan 5, 2021	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2021	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Dec 18, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Nov 30, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Nov 25, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Oct 5, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 11, 2020	Form 3	Avidity Biosciences RNA	Filing · EDGAR
May 26, 2020	Form 4/A	Stoke Therapeutics STOK	Filing · EDGAR
May 14, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 15, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Mar 26, 2020	Form 4	Stoke Therapeutics STOK	Filing · EDGAR
Feb 14, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 29, 2020	Form 4/A	Cytokinetics CYTK	Filing · EDGAR
Jan 6, 2020	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jun 18, 2019	Form 3	Stoke Therapeutics STOK	Filing · EDGAR
May 17, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2019	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 17, 2018	Form 4	Cytokinetics CYTK	Filing · EDGAR
Jan 4, 2018	Form 4	Cytokinetics CYTK	Filing · EDGAR
Aug 7, 2017	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jul 21, 2017	Form 4	Sarepta Therapeutics	Filing · EDGAR
May 22, 2017	Form 4	Cytokinetics CYTK	Filing · EDGAR
Apr 24, 2017	Form 4	Sarepta Therapeutics	Filing · EDGAR
Mar 14, 2017	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jan 24, 2017	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jan 4, 2017	Form 4	Cytokinetics CYTK	Filing · EDGAR
Nov 10, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Oct 24, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Sep 26, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Sep 21, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Sep 16, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Sep 2, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jul 22, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jul 5, 2016	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 20, 2016	Form 4	Cytokinetics CYTK	Filing · EDGAR
May 20, 2016	Form 3	Cytokinetics CYTK	Filing · EDGAR
Apr 22, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Mar 2, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jan 25, 2016	Form 4	Sarepta Therapeutics	Filing · EDGAR
Oct 22, 2015	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jul 31, 2015	Form 4	Sarepta Therapeutics	Filing · EDGAR
Apr 22, 2015	Form 4	Sarepta Therapeutics	Filing · EDGAR
Mar 3, 2015	Form 4	Sarepta Therapeutics	Filing · EDGAR
Mar 4, 2014	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jun 6, 2013	Form 4	Sarepta Therapeutics	Filing · EDGAR
Aug 27, 2012	Form 4	Sarepta Therapeutics	Filing · EDGAR
Apr 25, 2012	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jun 20, 2011	Form 4	Sarepta Therapeutics	Filing · EDGAR
Jun 20, 2011	Form 3	Sarepta Therapeutics	Filing · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched Nov 6, 2026, 2:09 PM ET. The filing on SEC.gov is the record.